372 related articles for article (PubMed ID: 25683673)
21. (p-ClPhSe)
Quines CB; Rosa SG; Velasquez D; Prado VC; Neto JSS; Nogueira CW
Food Chem Toxicol; 2018 Aug; 118():168-180. PubMed ID: 29738801
[TBL] [Abstract][Full Text] [Related]
22. Prolonged but not short negative energy condition restored corticoadrenal leptin sensitivity in the hypothalamic obese rat.
Perello M; Castrogiovanni D; Giovambattista A; Gaillard RC; Spinedi E
Neuroendocrinology; 2009; 89(3):276-87. PubMed ID: 19141989
[TBL] [Abstract][Full Text] [Related]
23. Nitrogen metabolism in obesity induced by monosodium-L-glutamate in rats.
Betrán MA; Estornell E; Barber T; Cabo J
Int J Obes Relat Metab Disord; 1992 Aug; 16(8):555-64. PubMed ID: 1326485
[TBL] [Abstract][Full Text] [Related]
24. Hormonal and metabolic adaptations to fasting in monosodium glutamate-obese rats.
Ribeiro EB; do Nascimento CM; Andrade IS; Hirata AE; Dolnikoff MS
J Comp Physiol B; 1997 Aug; 167(6):430-7. PubMed ID: 9286091
[TBL] [Abstract][Full Text] [Related]
25. Cross-fostering reduces obesity induced by early exposure to monosodium glutamate in male rats.
Miranda RA; da Silva Franco CC; de Oliveira JC; Barella LF; Tófolo LP; Ribeiro TA; Pavanello A; da Conceição EP; Torrezan R; Armitage J; Lisboa PC; de Moura EG; de Freitas Mathias PC; Vieira E
Endocrine; 2017 Jan; 55(1):101-112. PubMed ID: 27116693
[TBL] [Abstract][Full Text] [Related]
26. Taurine prevents fat deposition and ameliorates plasma lipid profile in monosodium glutamate-obese rats.
Nardelli TR; Ribeiro RA; Balbo SL; Vanzela EC; Carneiro EM; Boschero AC; Bonfleur ML
Amino Acids; 2011 Oct; 41(4):901-8. PubMed ID: 21042817
[TBL] [Abstract][Full Text] [Related]
27. Hypothalamic resistin immunoreactivity is reduced by obesity in the mouse: co-localization with alpha-melanostimulating hormone.
Wilkinson M; Wilkinson D; Wiesner G; Morash B; Ur E
Neuroendocrinology; 2005; 81(1):19-30. PubMed ID: 15809509
[TBL] [Abstract][Full Text] [Related]
28. Monosodium glutamate in standard and high-fiber diets: metabolic syndrome and oxidative stress in rats.
Diniz YS; Faine LA; Galhardi CM; Rodrigues HG; Ebaid GX; Burneiko RC; Cicogna AC; Novelli EL
Nutrition; 2005 Jun; 21(6):749-55. PubMed ID: 15925301
[TBL] [Abstract][Full Text] [Related]
29. Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice.
Roman-Ramos R; Almanza-Perez JC; Garcia-Macedo R; Blancas-Flores G; Fortis-Barrera A; Jasso EI; Garcia-Lorenzana M; Campos-Sepulveda AE; Cruz M; Alarcon-Aguilar FJ
Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):406-13. PubMed ID: 21205225
[TBL] [Abstract][Full Text] [Related]
30. Behavioral deficits in adult rats treated neonatally with glutamate.
Hlinák Z; Gandalovicová D; Krejcí I
Neurotoxicol Teratol; 2005; 27(3):465-73. PubMed ID: 15939206
[TBL] [Abstract][Full Text] [Related]
31. Cortical tau burden and behavioural dysfunctions in mice exposed to monosodium glutamate in early life.
Hassaan PS; Dief AE; Zeitoun TM; Baraka AM; Deacon RMJ; Elshorbagy A
PLoS One; 2019; 14(8):e0220720. PubMed ID: 31412065
[TBL] [Abstract][Full Text] [Related]
32. Effects of monosodium glutamate-induced obesity in spontaneously hypertensive rats vs. Wistar Kyoto rats: serum leptin and blood flow to brown adipose tissue.
Iwase M; Ichikawa K; Tashiro K; Iino K; Shinohara N; Ibayashi S; Yoshinari M; Fujishima M
Hypertens Res; 2000 Sep; 23(5):503-10. PubMed ID: 11016806
[TBL] [Abstract][Full Text] [Related]
33. Surgical removal of visceral fat decreases plasma free fatty acid and increases insulin sensitivity on liver and peripheral tissue in monosodium glutamate (MSG)-obese rats.
Kim YW; Kim JY; Lee SK
J Korean Med Sci; 1999 Oct; 14(5):539-45. PubMed ID: 10576150
[TBL] [Abstract][Full Text] [Related]
34. Components of hypothalamic obesity: bipiperidyl-mustard lesions add hyperphagia to monosodium glutamate-induced hyperinsulinemia.
Scallet AC; Olney JW
Brain Res; 1986 May; 374(2):380-4. PubMed ID: 3459567
[TBL] [Abstract][Full Text] [Related]
35. [The effect of neonatal administration of monosodium glutamate on behavior and blood corticosterone level].
Kuznetsova EG; Amstislavskaia TG; Bulygina VV; Il'nitskaia SI; Tibeĭkina MA; Skrinskaia IuA
Ross Fiziol Zh Im I M Sechenova; 2006 Jun; 92(6):751-60. PubMed ID: 16967872
[TBL] [Abstract][Full Text] [Related]
36. The induction of obesity in rodents by means of monosodium glutamate.
Bunyan J; Murrell EA; Shah PP
Br J Nutr; 1976 Jan; 35(1):25-39. PubMed ID: 1106764
[TBL] [Abstract][Full Text] [Related]
37. Vagotomy reduces obesity in MSG-treated rats.
Balbo SL; Mathias PC; Bonfleur ML; Alves HF; Siroti FJ; Monteiro OG; Ribeiro FB; Souza AC
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):291-6. PubMed ID: 11958282
[TBL] [Abstract][Full Text] [Related]
38. Glucose tolerance and insulin action in monosodium glutamate (MSG) obese exercise-trained rats.
de Mello MA; de Souza CT; Braga LR; dos Santos JW; Ribeiro IA; Gobatto CA
Physiol Chem Phys Med NMR; 2001; 33(1):63-71. PubMed ID: 11758736
[TBL] [Abstract][Full Text] [Related]
39. Obesity induced by neonatal treatment with monosodium glutamate impairs microvascular reactivity in adult rats: role of NO and prostanoids.
Lobato NS; Filgueira FP; Akamine EH; Davel AP; Rossoni LV; Tostes RC; Carvalho MH; Fortes ZB
Nutr Metab Cardiovasc Dis; 2011 Oct; 21(10):808-16. PubMed ID: 20554176
[TBL] [Abstract][Full Text] [Related]
40. Monosodium l-glutamate-obesity onset is associated with disruption of central control of the hypothalamic-pituitary-adrenal axis and autonomic nervous system.
Torrezan R; Malta A; de Souza Rodrigues WDN; Dos Santos AAA; Miranda RA; Moura EG; Lisboa PC; de Freitas Mathias PC
J Neuroendocrinol; 2019 Jun; 31(6):e12717. PubMed ID: 30929305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
